ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)

Volume 23, 46 Issues, 2017

Download PDF Flyer

Current Pharmaceutical Design

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

William A. Banks
Building 1, Room 810A
1600 S. Columbian Way
Seattle, WA 98108

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.611
5 - Year: 3

Abstracts Ahead of Print

The overlap between Binge Eating Behaviors and Polycystic Ovarian Syndrome: An etiological integrative model

Chiara Paganini*, Gregory Peterson, Vasilis Stavropoulos and Isabel Krug.

View Abstract

A review on oral liquid as an emerging technology in controlled drug delivery system.

Sangmesh Raosaheb Torne, Angappan Sheela* and N C Sarada.

View Abstract

Ensuring the consistency of biosimilars

Isabel Andujar Perez, Ana Blas-Garcia*, Loreto Carmona and Juan V Esplugues.

View Abstract

Immobilization techniques applied to the development of biocatalysts for the synthesis of nucleoside analogue derivatives

Jorge Abel Trelles* and Maria Jose Lapponiab.

View Abstract

The experience with biosimilars of infliximab in inflammatory bowel disease

Pedro Avila-Ribeiro*, Gionata Fiorino and Silvio Danese.

View Abstract

Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach

Mark McCully, Macarena Sanchez-Navarro , Meritxell Teixido* and Ernest Giralt*.

View Abstract

FDG PET/CT Imaging in Diabetic Patients – A Special Emphasis on Imaging of Infection

Zohar Keidar*.

View Abstract

Past and future of Ga-citrate for infection and inflammation imaging

Mariza Vorster, J Buscombe*, Ziauddin Saad and Mike Sathekge.

View Abstract

Nuclear Medicine Imaging in Fever of Unknown Origin: The New Paradigm

Christopher J Palestro* and Charito Love.

View Abstract

Risk Assessment and Monitoring of Antibody Responses to Biosimilars in Chronic Inflammatory Diseases

Iris Detrez and Ann Gils*.

View Abstract

The economic impact of biosimilars on chronic immune-mediated inflammatory diseases

Marta Pentek*, Zsombor Zrubka and Laszlo Gulacsi.

View Abstract

Biosimilars: From extrapolation into off label use

Sizheng Zhao, Jagdish R Nair and Robert J Moots*.

View Abstract

The Experience With Biosimilars Of Infliximab In Rheumatic Diseases

Valderilio Feijó Azevedo, Igor Age Kos and Leonardo Ariello.

View Abstract

The Role of Biosimilars in Patient Access to Therapeutic Antibodies for Immune Mediated Inflammatory Diseases

Mary Ann Chapman*, David Charles and Arturo Loaiza-Bonilla.

View Abstract

Lipid nanoparticles for the delivery of active natural medicines

Huijie Xing, Huan Wang, Baojian Wu and Xingwang Zhang*.

View Abstract

Intranasal lipid nanoparticles for the treatment of neurodegenerative diseases

S. Cunha, H. Almeida, M. H. Amaral*, J. M. Sousa Lobo and A C Silva*.

View Abstract

Platform for Lipid Based Nanocarriers’ Formulation Components and their Potential Effects: A Literature Review

Ragwa Mohamed Farid*, Nancy Abdel Hamid Abou Youssef and Abeer Ahmed Kassem.

View Abstract

Imaging of bacteria: is there any hope for the future based on past experience?

Thomas Ebenhan, Elena Lazzeri and Olivier Gheysens*.

View Abstract

Comparative Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Phase Regimen

Cody P. Coyne* and Lakshmi Narayanan.

View Abstract

Design and delivery of therapeutic siRNAs: application to MERS-Coronavirus

Sayed Sartaj Sohrab*, Sherif Aly El-Kafrawy, Zeenat Mirza, Mohammad Amjad Kamal and Esam Ibraheem Azhar.

View Abstract

Polyphenols: inflammation

Midori Natsume*.

View Abstract

Polyphenols and Microvascular Function in Humans: A Systematic Review

Kirsty A. Woodward, Richard Draijer, Dick H. J. Thijssen and David A Low*.

View Abstract

Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors

William B. Parker and Eric J Sorscher*.

View Abstract

Substrate spectra of nucleoside phosphorylases and their potential in the production of pharmaceutically active compounds

Heba Yehia, Sarah Kamel, Katharina Paulick, Peter Neubauer and Anke Wagner*.

View Abstract

Influence of Length and Amino Acid Composition on Dimer Formation of Immunoglobulin based Chimera

Patidar Manoj, Yadav Naveen and Sarat Kumar Dalai*.

View Abstract

RNA Therapeutics

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science